Cargando…

Evaluation of Plasma Soluble Urokinase Plasminogen Activator Receptor Levels in Patients With COVID-19 and Non-COVID-19 Pneumonia: An Observational Cohort Study

BACKGROUND: The respiratory system is the main system affected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and a great number of infected people need hospitalization. Soluble urokinase plasminogen activator receptor (suPAR) is a biomarker indicative of acute and chronic infl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Velissaris, Dimitrios, Lagadinou, Maria, Paraskevas, Themistoklis, Oikonomou, Eleousa, Karamouzos, Vasileios, Karteri, Sofia, Bousis, Dimitrios, Pantzaris, Nikolaos, Tsiotsios, Konstantinos, Marangos, Markos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510652/ https://www.ncbi.nlm.nih.gov/pubmed/34691321 http://dx.doi.org/10.14740/jocmr4579

Ejemplares similares

Evaluation of Admission Chest X-Ray Findings in Patients With Respiratory Infection During the COVID-19 Pandemic
por: Velissaris, Dimitrios, et al.
Publicado: (2021)

Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Percentage Ratio as Predictors of In-hospital Mortality in Sepsis. An Observational Cohort Study
por: Karamouzos, Vasileios, et al.
Publicado: (2022)

Soluble Urokinase Plasminogen Activator Receptor as a Diagnostic and Prognostic Biomarker in Cardiac Disease
por: Velissaris, Dimitrios, et al.
Publicado: (2021)

Soluble urokinase plasminogen activator receptor (suPAR) in the emergency department: An update
por: Velissaris, Dimitrios, et al.
Publicado: (2022)

Peripheral Inserted Central Catheter Use and Related Infections in Clinical Practice: A Literature Update
por: Velissaris, Dimitrios, et al.
Publicado: (2019)

Impact of Bacterial Infections on COVID-19 Patients: Is Timing Important?
por: Michailides, Christos, et al.
Publicado: (2023)

Alterations in Laboratory Parameters Related to Disease Severity in Vaccinated Patients Against SARS-CoV-2
por: Lagadinou, Maria, et al.
Publicado: (2022)

Knowledge and Attitudes of Healthcare Workers towards Antibiotic Use and Antimicrobial Resistance in Two Major Tertiary Hospitals in Western Greece
por: Lagadinou, Maria, et al.
Publicado: (2023)

The Role of the Pancreatic Stone Protein in Predicting Intra-Abdominal Infection-Related Complications: A Prospective Observational Single-Center Cohort Study
por: Michailides, Christos, et al.
Publicado: (2023)

Renin Inhibition with Aliskiren: A Decade of Clinical Experience
por: Pantzaris, Nikolaos-Dimitrios, et al.
Publicado: (2017)

A Literature Review of Pathophysiology, Clinical Manifestations, Medications and Optimal Dosage, Outpatient, and Post-hospitalization Use of Anticoagulation in COVID-19 Patients
por: Velissaris, Dimitrios, et al.
Publicado: (2023)

Myocarditis Caused by Brucella melitensis in the Absence of Endocarditis: Case Report and Review of the Literature
por: Lagadinou, Maria, et al.
Publicado: (2019)

Pharmacokinetic Changes and Dosing Modification of Aminoglycosides in Critically Ill Obese Patients: A Literature Review
por: Velissaris, Dimitrios, et al.
Publicado: (2014)

Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19
por: Luo, Shengyuan, et al.
Publicado: (2022)

Relation Between Central Venous, Peripheral Venous and Arterial Lactate Levels in Patients With Sepsis in the Emergency Department
por: Velissaris, Dimitrios, et al.
Publicado: (2019)

The Use of Electroencephalography in Patients with Sepsis: a Review of The Literature
por: Pantzaris, Nikolaos-Dimitrios, et al.
Publicado: (2021)

Correlation of Positive Blood Cultures with Peripherally Inserted Central Catheter Line Infection in Oncology Patients
por: Platanaki, Christina, et al.
Publicado: (2021)

Prolonged high-dose intravenous magnesium therapy for severe tetanus in the intensive care unit: a case series
por: Karanikolas, Menelaos, et al.
Publicado: (2010)

Prognostic Role of Soluble Urokinase Plasminogen Activator Receptor at the Emergency Department: A Position Paper by the Hellenic Sepsis Study Group
por: Velissaris, Dimitrios, et al.
Publicado: (2020)

Soluble urokinase plasminogen activator receptor levels are predictive of COVID-19 severity in Afro-Caribbean patients
por: Padelli, Mael, et al.
Publicado: (2022)

Are Patients With Autoimmune Disease at Greater Risk of Developing Severe COVID-19?
por: Lagadinou, Maria, et al.
Publicado: (2020)

Comparison of the Mortality Prediction Value of Soluble Urokinase Plasminogen Activator Receptor (suPAR) in COVID-19 and Sepsis
por: Vassiliou, Alice G., et al.
Publicado: (2022)

Soluble urokinase Plasminogen Activator Receptor (suPAR) levels are predictive of COVID-19 severity: an Italian experience
por: Infantino, Maria, et al.
Publicado: (2022)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017)

Red Blood Cell Distribution Width: Another Prognostic Factor for COVID-19?
por: Lagadinou, Maria, et al.
Publicado: (2021)

The Role of Procalcitonin in the Diagnosis of Meningitis: A Literature Review
por: Velissaris, Dimitrios, et al.
Publicado: (2018)

Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients
por: Chalkias, Athanasios, et al.
Publicado: (2020)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Independently Predicts Severity and Length of Hospitalisation in Patients With COVID-19
por: Enocsson, Helena, et al.
Publicado: (2021)

WITHDRAWN: Soluble urokinase plasminogen activator receptor and its complicated role in hemodialysis (HD) patients with Covid-19 infection
por: Griveas, Ioannis, et al.
Publicado: (2022)

Electroencephalographic Abnormalities in Sepsis Patients in Correlation to the Calculated Prognostic Scores: A Case Series
por: Velissaris, Dimitrios, et al.
Publicado: (2018)

SARS CoV-2-Induced Viral Sepsis: The Role of Gut Barrier Dysfunction
por: Assimakopoulos, Stelios F., et al.
Publicado: (2022)

Soluble Urokinase Plasminogen Activator Receptor as a Marker for Use of Antidepressants
por: Haastrup, Eva, et al.
Publicado: (2014)

Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
por: Godtfredsen, Nina S., et al.
Publicado: (2018)

Soluble urokinase plasminogen activator receptor for the prediction of ventilator-associated pneumonia
por: van Oort, Pouline M., et al.
Publicado: (2019)

Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis
por: Garnæs, Emilie, et al.
Publicado: (2019)

Soluble urokinase plasminogen activator receptor level in individuals of advanced age
por: Wlazel, Rafal N., et al.
Publicado: (2020)

Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia
por: Rovina, Nikoletta, et al.
Publicado: (2020)

Soluble Urokinase Plasminogen Activator Receptor as a Decision Marker for Early Discharge of Patients with COVID-19 Symptoms in the Emergency Department
por: Stauning, Marius Ahm, et al.
Publicado: (2021)

C-Reactive Protein and Frailty in the Elderly: A Literature Review
por: Velissaris, Dimitrios, et al.
Publicado: (2017)

High-Flow vs. Low-Flow Nasal Cannula in Reducing Hypoxemic Events During Bronchoscopic Procedures: A Systematic Review and Meta-Analysis
por: Sampsonas, Fotios, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0thu8cf55alhpq6q9993aogrmr